Clinical Trial Update: Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating safety and effectiveness of quercetin and dasatinib on epigenetic aging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging

Drugs mentioned

• DASATINIB (Dasatinib)
• Quercetin (quercetin)

Snippet

Sponsor: TruDiagnostic | Conditions: Aging | Phase 2 | Status: UNKNOWN